These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9921992)

  • 21. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
    Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
    Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Somatostatin receptor status in non-medullary thyroid carcinoma].
    Görges R; Kahaly G; Müller-Brand J; Mäcke H; Walgenbach S; Bruns C; Andreas J; Brandt-Mainz K; Bockisch A
    Nuklearmedizin; 1999; 38(1):15-23. PubMed ID: 9987777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin receptors and breast cancer.
    van Eijck CH; Kwekkeboom DJ; Krenning EP
    Q J Nucl Med; 1998 Mar; 42(1):18-25. PubMed ID: 9646641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
    Lamberts SW; Reubi JC; Krenning EP
    Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo detection of somatostatin receptors in human malignant tissues.
    Reubi JC; Kvols L; Krenning E; Lamberts SW
    Acta Oncol; 1991; 30(4):463-8. PubMed ID: 1649613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioguided surgery with radiolabeled somatostatin analogs: not only in GEP-NETs.
    Cuccurullo V; Di Stasio GD; Mansi L
    Nucl Med Rev Cent East Eur; 2017; 20(1):49-56. PubMed ID: 28218348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory peptide receptors in human hepatocellular carcinomas.
    Reubi JC; Zimmermann A; Jonas S; Waser B; Neuhaus P; Läderach U; Wiedenmann B
    Gut; 1999 Nov; 45(5):766-74. PubMed ID: 10517918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
    Ling ZN; Hong LL; Wu J; Ling ZQ
    Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging tumors with peptide-based radioligands.
    Behr TM; Gotthardt M; Barth A; Béhé M
    Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin receptors in malignant tissues.
    Reubi JC; Krenning E; Lamberts SW; Kvols L
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1073-7. PubMed ID: 1981010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.
    Virgolini I; Raderer M; Kurtaran A; Angelberger P; Banyai S; Yang Q; Li S; Banyai M; Pidlich J; Niederle B; Scheithauer W; Valent P
    N Engl J Med; 1994 Oct; 331(17):1116-21. PubMed ID: 7935635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.
    Waser B; Rehmann R; Sanchez C; Fourmy D; Reubi JC
    J Clin Endocrinol Metab; 2012 Feb; 97(2):482-8. PubMed ID: 22112810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin receptors in human prostate and prostate cancer.
    Reubi JC; Waser B; Schaer JC; Markwalder R
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2806-14. PubMed ID: 7673428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pancreatic metastases of renal cell carcinomas - evaluation of the contrast behavior at echo-enhanced power-Doppler sonography in comparison to primary pancreatic tumors].
    Rickes S; Flath B; Unkrodt K; Ocran K; Neye H; Lochs H; Wermke W
    Z Gastroenterol; 2001 Aug; 39(8):571-8. PubMed ID: 11558060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin receptors in the gastrointestinal tract in health and disease.
    Reubi JC
    Yale J Biol Med; 1992; 65(5):493-503; discussion 531-6. PubMed ID: 1340064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro detection of somatostatin receptors in human tumors.
    Reubi JC; Krenning E; Lamberts SW; Kvols L
    Digestion; 1993; 54 Suppl 1():76-83. PubMed ID: 8103015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.